CEPI and GSK announced collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
On Feb. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, and GSK announced a new collaboration aimed…
On Feb. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, and GSK announced a new collaboration aimed…
On Jan. 31, 2020, Vaxart announced it had initiated a program to develop a coronavirus vaccine candidate based…
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
On Jan. 27, 2020, GSK announced that it had licensed its M72/AS01E[3] tuberculosis disease (TB) vaccine candidate to…
On Jan. 24, 2020, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
On Jan. 23, 2020, two independent meningitis B studies were published in the New England Journal of Medicine…
On Jan. 23, 2020, Moderna announced a new collaboration to develop an mRNA vaccine against the novel coronavirus…
On Jan. 14, 2020, Valneva announced that the U.S. Department of Defense (DoD) had exercised an option to…
On Dec. 27, 2019, Sinovac Biotech announced that the China National Medical Products Administration (NMPA) had approved and…
On Dec. 25, 2019, Medigen Vaccine Biologics (MVB) announced it had completed the enrollment of phase III multi-region…
On Dec. 20, 2019, Vaccitech’s partner, the University of Oxford’s Jenner Institute, in collaboration with The King Abdullah…
On Dec. 19, 2019, the WHO announced that PNEUMOSIL, a vaccine against a leading cause of deadly childhood…
On Dec. 13, 2019, the Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee (ACIP)…
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Oct. 30, 2019, researchers at the University of Georgia’s Center for the Ecology of Infectious Diseases received…
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
On Sept. 30, 2019, the University of Georgia (UGA) announced it had signed a contract with the National…
On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…
On Sept. 24, 2019, the American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College…
On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ᅠleaseᅠ…
On Aug. 23, 2019, the Centers for Disease Control and Prevention (CDC) released Immunization Practices Advisory Committee (ACIP)…
On Aug. 16, 2019, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
On Jul. 19, 2019, the Centers for Disease Control and Prevention (CDC) published recommendations from the Advisory Committee…
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
On Jun. 20, 2019, CanSino Biologics announced that it had received the National Medical Products Administration’s (NMPA) permission…
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
On Jun. 5, 2019, Vaccitech announced that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100)…
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…